Posted by Michael Wonder on 23 Dec 2025
FDA approves Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults
22 December 2025 - 1.5 mg starting dose available in early January for $149/month with savings offers; Wegovy pill is being produced in the US and robust supply is on hand.
Novo Nordisk today announced that the US FDA has approved oncedaily Wegovy pill, the first oral GLP-1 medicine for obesity in the US.
